Palvella Therapeutics, Inc.
PVLA
$91.78
$0.190.21%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 63.57M | 70.43M | 75.63M | 83.60M | 14.21M |
| Total Receivables | 2.22M | 1.98M | 1.98M | 2.34M | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 1.15M | 1.34M | 1.84M | 2.30M | 441.00K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | 1.67M |
| Total Current Assets | 66.94M | 73.75M | 79.44M | 88.23M | 16.32M |
|
|
|||||
| Total Current Assets | 66.94M | 73.75M | 79.44M | 88.23M | 16.32M |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 66.94M | 73.75M | 79.44M | 88.23M | 16.32M |
|
|
|||||
| Total Accounts Payable | 3.48M | 4.56M | 4.44M | 4.59M | 3.13M |
| Total Accrued Expenses | 3.56M | 2.16M | 1.74M | 4.29M | 4.22M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | 3.27M | 2.90M | 2.80M | 3.17M | 282.00K |
| Total Other Current Liabilities | 3.27M | 2.90M | 2.80M | 3.17M | 282.00K |
| Total Current Liabilities | 10.31M | 9.62M | 8.98M | 12.04M | 7.64M |
|
|
|||||
| Total Current Liabilities | 10.31M | 9.62M | 8.98M | 12.04M | 7.64M |
| Long-Term Debt | 16.02M | 14.51M | 13.16M | 11.94M | 24.07M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 1.92M | 1.84M | 1.72M | 1.65M | 1.42M |
| Total Liabilities | 28.26M | 25.97M | 23.86M | 25.63M | 33.12M |
|
|
|||||
| Common Stock & APIC | 161.31M | 159.28M | 157.50M | 156.34M | 2.38M |
| Retained Earnings | -122.74M | -111.39M | -101.92M | -93.74M | -89.78M |
| Treasury Stock & Other | 104.00K | -111.00K | -3.00K | 3.00K | -- |
| Total Common Equity | 38.68M | 47.78M | 55.58M | 62.61M | -87.40M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | 70.60M |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | 70.60M |
|
|
|||||
| Total Common Equity | 38.68M | 47.78M | 55.58M | 62.61M | -87.40M |
| Total Preferred Equity | -- | -- | -- | -- | 70.60M |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 38.68M | 47.78M | 55.58M | 62.61M | -16.80M |
|
|
|||||